Project Grant R01NS144538
- The National Institute of Neurological Disorders and Stroke awarded Washington University $231,264 on April 8, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to identify and validate cerebroprotective drug targets in humans with acute ischemic stroke caused by large vessel occlusion. The research collects paired periprocedural arterial blood samples during endovascular thrombectomy procedures at Barnes-Jewish Hospital/Washington...
- The National Institute of Neurological Disorders and Stroke awarded the University of Texas at Austin $393,284 on June 13, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct basic research on synaptic structural plasticity and stroke rehabilitation. The project examines how the brain remodels neural circuitry following stroke, with focus on reactive synaptogenesis—the growth of new connections among surviving neurons near...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded $433,125 to the University of Texas Health Science Center at San Antonio on August 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the role of REST (Restrictive Element-1 Silencing Transcription Factor) in governing post-stroke neural plasticity and recovery. The...
- The National Institute of Neurological Disorders and Stroke awarded The Washington University $618,077 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop next-generation tools for human cortical cartography. The award funds generation of a multi-modal atlas of human cortical areas with improved accuracy beyond the 2016 version, characterization of individual variability and subareal organization within cortical...
- The National Institute of Neurological Disorders and Stroke awarded The Washington University $618,108 on June 18, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct research on neuroinflammation in cerebral small vessel disease, a leading vascular contributor to cognitive impairment and dementia. The recipient will evaluate the relationship between 11C-CS1P1 PET uptake—a novel positron emission tomography radiotracer...
- The National Institute of Neurological Disorders and Stroke awarded Washington University in St. Louis $493,332 on August 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop a surface electroneurography device for in-office assessment of peripheral nerve recovery. Washington University partnered with Biocircuit Technologies to design a diagnostic system addressing limitations in current peripheral nerve injury...
- The National Institute of Neurological Disorders and Stroke awarded The Washington University $245,874 on July 2, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop therapies that reprogram astrocytes to promote neural repair following spinal cord injury. The research defines pro-regenerative glial cell reactivity in zebrafish, performs an in vivo CRISPR screen to identify transcription regulators of that reactivity,...
- The National Institute of Neurological Disorders and Stroke awarded The Washington University $427,625 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on September 1, 2026, for research on imaging fibrosis formation in peripheral nerve injury. The award funds a two-year proof-of-principle study addressing fibrosis complications in surgical repair of severe peripheral nerve injuries. Research Aim 1 focuses on real-time visualization...
- The National Institute of Neurological Disorders and Stroke awarded $588,794 to the University of South Florida on July 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research investigating the functions of microglial laminin in blood-brain barrier repair and microglial activation following ischemic stroke. The research encompasses three aims: examining the function of microglial laminin in stroke...
- The National Institute of Neurological Disorders and Stroke awarded the University of Wisconsin–Madison $494,240 on February 16, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate target-directed microRNA degradation in post-stroke brain tissue. The project examines how microRNA-7 is depleted following stroke despite intact biogenesis, hypothesizing that target-directed microRNA degradation (TDMD) drives this loss....
The National Institute of Neurological Disorders and Stroke awarded The Washington University $617,439 on July 21, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to examine how lesion location and extent affect post-stroke neuroplasticity and recovery mechanisms. The project will use rat stroke models with varying lesion sizes and locations—systematically manipulating damage to the corticospinal tract and lesions in the cortex or internal capsule—to determine whether the contralesional hemisphere's role in recovery depends on lesion characteristics. The research employs electrophysiology, functional imaging, and cortical inactivation to test the bimodal balance recovery model, which predicts that recovery mechanisms vary based on corticospinal tract integrity: incomplete infarcts recover through restored interhemispheric balance, while complete infarcts depend on the unaffected hemisphere. The work addresses the gap between animal models with uniform lesions and human stroke patients who present heterogeneous lesion profiles, aiming to improve translation of recovery mechanisms into targeted interventions. The award runs through June 30, 2031, with place of performance in St. Louis, Missouri. The Washington University's Office of Sponsored Research Services Division serves as the recipient organization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $617.4k | 7/30/26 |